Main Content
latest…
Xebec Adsorption has an exceptional growth profile, says Beacon
Beacon Securities analyst Ahmad Shaath on Friday delivered an update on Xebec Adsorption (Xebec … Keep reading
More recent headlines
Cannabis
Canopy Rivers has a 149 per-cent upside, GMP Securities says
Further clarity on the company’s EBITDA potential leaves GMP Securities analyst Martin Landry feeling even more bullish on cannabis sector play Canopy … Read More
See related
Stock Picks
Xebec Adsorption has an exceptional growth profile, says Beacon
Beacon Securities analyst Ahmad Shaath on Friday delivered an update on Xebec Adsorption (Xebec Adsorption Stock Quote, Chart TSXV:XBC), saying that … Read more
See related
Life Sciences Stocks
Antibe Therapeutics has an upside of 352 per cent, Echelon Wealth says
In an update to clients Wednesday, Echelon Wealth Partners analyst Douglas Loe remains bullish on … Keep reading
ProMetic Life Sciences is not out of the woods yet, Echelon Wealth says
Echelon Wealth Partners analyst Douglas Loe says ProMetic Life Sciences (ProMetic Life Sciences … Keep reading
Aurinia Pharma is undervalued, Mackie Research says
An executive shakeup by drug developer Aurinia Pharmaceuticals (Aurinia Pharmaceuticals Stock Quote, … Keep reading
Profound Medical has 400 per cent upside, says Paradigm Capital
Upcoming catalysts are reason to get interested in medical device company Profound Medical (Profound … Keep reading
Buy Oncolytics Biotech for a 331 per cent return, Echelon Wealth says
Echelon Wealth Partners analyst Doug Loe thinks cancer biologics company Oncolytics Biotech … Keep reading
